169 related articles for article (PubMed ID: 27476138)
1. An efficient chelator for complexation of thorium-227.
Ramdahl T; Bonge-Hansen HT; Ryan OB; Larsen S; Herstad G; Sandberg M; Bjerke RM; Grant D; Brevik EM; Cuthbertson AS
Bioorg Med Chem Lett; 2016 Sep; 26(17):4318-21. PubMed ID: 27476138
[TBL] [Abstract][Full Text] [Related]
2. Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Hagemann UB; Wickstroem K; Hammer S; Bjerke RM; Zitzmann-Kolbe S; Ryan OB; Karlsson J; Scholz A; Hennekes H; Mumberg D; Cuthbertson AS
Cancer Biother Radiopharm; 2020 Sep; 35(7):497-510. PubMed ID: 32255671
[TBL] [Abstract][Full Text] [Related]
3. Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy.
Deblonde GJ; Lohrey TD; Booth CH; Carter KP; Parker BF; Larsen Å; Smeets R; Ryan OB; Cuthbertson AS; Abergel RJ
Inorg Chem; 2018 Nov; 57(22):14337-14346. PubMed ID: 30372069
[TBL] [Abstract][Full Text] [Related]
4. A macrocyclic chelator with unprecedented Th⁴⁺ affinity.
Pham TA; Xu J; Raymond KN
J Am Chem Soc; 2014 Jun; 136(25):9106-15. PubMed ID: 24870296
[TBL] [Abstract][Full Text] [Related]
5. Thorium chelators for targeted alpha therapy: Rapid chelation of thorium-226.
Ferrier MG; Li Y; Chyan MK; Wong R; Li L; Spreckelmeyer S; Hamlin DK; Mastren T; Fassbender ME; Orvig C; Wilbur DS
J Labelled Comp Radiopharm; 2020 Oct; 63(12):502-516. PubMed ID: 32812275
[TBL] [Abstract][Full Text] [Related]
6. Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers.
Hagemann UB; Ellingsen C; Schuhmacher J; Kristian A; Mobergslien A; Cruciani V; Wickstroem K; Schatz CA; Kneip C; Golfier S; Smeets R; Uran S; Hennekes H; Karlsson J; Bjerke RM; Ryan OB; Mumberg D; Ziegelbauer K; Cuthbertson AS
Clin Cancer Res; 2019 Aug; 25(15):4723-4734. PubMed ID: 31064781
[TBL] [Abstract][Full Text] [Related]
7. Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions.
Deblonde GJ; Sturzbecher-Hoehne M; Abergel RJ
Inorg Chem; 2013 Aug; 52(15):8805-11. PubMed ID: 23855806
[TBL] [Abstract][Full Text] [Related]
8. Thorium(IV) complexes of bidentate hydroxypyridinonates.
Xu J; Whisenhunt DW; Veeck AC; Uhlir LC; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2665-74. PubMed ID: 12691574
[TBL] [Abstract][Full Text] [Related]
9. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
Xu J; Kullgren B; Durbin PW; Raymond KN
J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
[TBL] [Abstract][Full Text] [Related]
10. Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator-Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms.
Captain I; Deblonde GJ; Rupert PB; An DD; Illy MC; Rostan E; Ralston CY; Strong RK; Abergel RJ
Inorg Chem; 2016 Nov; 55(22):11930-11936. PubMed ID: 27802058
[TBL] [Abstract][Full Text] [Related]
11. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
Deri MA; Ponnala S; Kozlowski P; Burton-Pye BP; Cicek HT; Hu C; Lewis JS; Francesconi LC
Bioconjug Chem; 2015 Dec; 26(12):2579-91. PubMed ID: 26550847
[TBL] [Abstract][Full Text] [Related]
12. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and spectral characterization of U(VI) and Th(IV) complexes of thenoylpyrazolone-ethylenediamine].
Li JZ; An YM; Yu WJ; Sha JQ
Guang Pu Xue Yu Guang Pu Fen Xi; 2002 Dec; 22(6):938-40. PubMed ID: 12914169
[TBL] [Abstract][Full Text] [Related]
15. Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.
Bhupathiraju NVSDK; Younes A; Cao M; Ali J; Cicek HT; Tully KM; Ponnala S; Babich JW; Deri MA; Lewis JS; Francesconi LC; Drain CM
Org Biomol Chem; 2019 Jul; 17(28):6866-6871. PubMed ID: 31268109
[TBL] [Abstract][Full Text] [Related]
16. Targeted Alpha Therapy with Thorium-227.
Frantellizzi V; Cosma L; Brunotti G; Pani A; Spanu A; Nuvoli S; De Cristofaro F; Civitelli L; De Vincentis G
Cancer Biother Radiopharm; 2020 Aug; 35(6):437-445. PubMed ID: 31967907
[TBL] [Abstract][Full Text] [Related]
17. [Thorium a radioactive element in current use: physical-chemical properties and biological processing].
Laroche P; Tymen H; Petitot F; Cazoulat A; Rotger C; Gérasimo P
Ann Pharm Fr; 1998; 56(3):115-22. PubMed ID: 9770018
[TBL] [Abstract][Full Text] [Related]
18. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.
Zhou X; Dong L; Shen L
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834087
[TBL] [Abstract][Full Text] [Related]
19. A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of
Buchwalder C; Rodríguez-Rodríguez C; Schaffer P; Karagiozov SK; Saatchi K; Häfeli UO
Dalton Trans; 2017 Jul; 46(29):9654-9663. PubMed ID: 28713886
[TBL] [Abstract][Full Text] [Related]
20. New hydroxypyridinone-functionalized sepharoses as sorbing agents for hard metal ions.
Grazina R; Santos MA
J Hazard Mater; 2011 Feb; 186(2-3):1902-8. PubMed ID: 21239106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
